361 related articles for article (PubMed ID: 17095716)
61. Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles?
Mirone V; Imbimbo C; Fusco F; Verze P; Creta M; Tajana G
Eur Urol; 2009 Aug; 56(2):309-16. PubMed ID: 19147269
[TBL] [Abstract][Full Text] [Related]
62. A poly(ADP-ribose) synthetase inhibitor, benzamide protects smooth muscle cells but not endothelium against ischemia/reperfusion injury in isolated guinea-pig heart.
Jakubowski A; Lomnicka M
Acta Biochim Pol; 2007; 54(1):199-204. PubMed ID: 17369883
[TBL] [Abstract][Full Text] [Related]
63. The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1.
Kusch A; Tkachuk S; Tkachuk N; Patecki M; Park JK; Dietz R; Haller H; Dumler I
Cardiovasc Res; 2009 Jul; 83(1):115-22. PubMed ID: 19380416
[TBL] [Abstract][Full Text] [Related]
64. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
[TBL] [Abstract][Full Text] [Related]
65. Regulation of endothelial prostacyclin synthesis by protease-activated receptors: mechanisms and significance.
Wheeler-Jones CP
Pharmacol Rep; 2008; 60(1):109-18. PubMed ID: 18276992
[TBL] [Abstract][Full Text] [Related]
66. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
Hollenberg MD
J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
[TBL] [Abstract][Full Text] [Related]
67. Stimulation of oestrogen receptor-expressing endothelial cells with oestrogen reduces proliferation of cocultured vascular smooth muscle cells.
Odenlund M; Ekblad E; Nilsson BO
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):245-8. PubMed ID: 18290870
[TBL] [Abstract][Full Text] [Related]
68. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.
Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S
Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431
[TBL] [Abstract][Full Text] [Related]
69. Mutation of the circadian clock gene Per2 alters vascular endothelial function.
Viswambharan H; Carvas JM; Antic V; Marecic A; Jud C; Zaugg CE; Ming XF; Montani JP; Albrecht U; Yang Z
Circulation; 2007 Apr; 115(16):2188-95. PubMed ID: 17404161
[TBL] [Abstract][Full Text] [Related]
70. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
71. Protease activated receptor 2 and the cardiovascular system.
Cicala C
Br J Pharmacol; 2002 Jan; 135(1):14-20. PubMed ID: 11786474
[No Abstract] [Full Text] [Related]
72. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
[TBL] [Abstract][Full Text] [Related]
73. The 5 lipoxygenase system in the vasculature: emerging role in health and disease.
Osher E; Weisinger G; Limor R; Tordjman K; Stern N
Mol Cell Endocrinol; 2006 Jun; 252(1-2):201-6. PubMed ID: 16647809
[TBL] [Abstract][Full Text] [Related]
74. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis.
Brunner F; Brás-Silva C; Cerdeira AS; Leite-Moreira AF
Pharmacol Ther; 2006 Aug; 111(2):508-31. PubMed ID: 16457892
[TBL] [Abstract][Full Text] [Related]
75. Developing PAR1 antagonists: minding the endothelial gap.
Ramachandran R
Discov Med; 2012 Jun; 13(73):425-31. PubMed ID: 22742648
[TBL] [Abstract][Full Text] [Related]
76. Structure, function and pathophysiology of protease activated receptors.
Adams MN; Ramachandran R; Yau MK; Suen JY; Fairlie DP; Hollenberg MD; Hooper JD
Pharmacol Ther; 2011 Jun; 130(3):248-82. PubMed ID: 21277892
[TBL] [Abstract][Full Text] [Related]
77. Protease-activated receptors in hemostasis, thrombosis and vascular biology.
Coughlin SR
J Thromb Haemost; 2005 Aug; 3(8):1800-14. PubMed ID: 16102047
[TBL] [Abstract][Full Text] [Related]
78. The role of protease-activated receptors on the intracellular calcium ion dynamics of vascular smooth muscles, with special reference to cerebral arterioles.
Misaki T; Satoh Y; Saino T; Ogawa A
Arch Histol Cytol; 2006 Mar; 69(1):49-60. PubMed ID: 16609269
[TBL] [Abstract][Full Text] [Related]
79. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
Steinhoff M; Buddenkotte J; Shpacovitch V; Rattenholl A; Moormann C; Vergnolle N; Luger TA; Hollenberg MD
Endocr Rev; 2005 Feb; 26(1):1-43. PubMed ID: 15689571
[TBL] [Abstract][Full Text] [Related]
80. [1998 Nobel Prize in physiology or medicine. Nitric oxide as a signal molecule in the cardiovascular system].
Hansson GK; Jörnvall H; Lindahl SG
Lakartidningen; 1998 Oct; 95(43):4703-8. PubMed ID: 9821753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
